Cargando…
CMTM6 drives cisplatin resistance by regulating Wnt signaling through the ENO-1/AKT/GSK3β axis
Rewiring tumor cells to undergo drug-induced apoptosis is a promising way to overcome chemoresistance. Therefore, identifying causative factors for chemoresistance is of high importance. Unbiased global proteome profiling of sensitive, early, and late cisplatin-resistant oral squamous cell carcinoma...
Autores principales: | Mohapatra, Pallavi, Shriwas, Omprakash, Mohanty, Sibasish, Ghosh, Arup, Smita, Shuchi, Kaushik, Sandeep Rai, Arya, Rakesh, Rath, Rachna, Das Majumdar, Saroj Kumar, Muduly, Dillip Kumar, Raghav, Sunil K., Nanda, Ranjan K., Dash, Rupesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934946/ https://www.ncbi.nlm.nih.gov/pubmed/33434185 http://dx.doi.org/10.1172/jci.insight.143643 |
Ejemplares similares
-
The Impact of m6A RNA Modification in Therapy Resistance of Cancer: Implication in Chemotherapy, Radiotherapy, and Immunotherapy
por: Shriwas, Omprakash, et al.
Publicado: (2021) -
CRISPR-based kinome-screening revealed MINK1 as a druggable player to rewire 5FU-resistance in OSCC through AKT/MDM2/p53 axis
por: Mohanty, Sibasish, et al.
Publicado: (2022) -
A Dosimetric Study Comparing 3D-CRT vs. IMRT vs. VMAT in Left-Sided Breast Cancer Patients After Mastectomy at a Tertiary Care Centre in Eastern India
por: Das Majumdar, Saroj Kumar, et al.
Publicado: (2022) -
Management of primary squamous cell carcinoma of the pancreas with a nanosomal paclitaxel lipid suspension-based regimen: A case report
por: Kumar Das Majumdar, Saroj, et al.
Publicado: (2019) -
Identification of CMTM6 and CMTM4 as PD-L1 protein
regulators
por: Mezzadra, Riccardo, et al.
Publicado: (2017)